Matches in Nanopublications for { ?s ?p "Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NX_Q9NZC7-1_MUTAGEN_33_33.RAkZW9-wHr6i68l9-OGnoCTJFe3cqbuP7suiEc7pPMZp8._4 comment "Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." NX_Q9NZC7-1_MUTAGEN_33_33.RAkZW9-wHr6i68l9-OGnoCTJFe3cqbuP7suiEc7pPMZp8.assertion.
- NX_Q9NZC7-2_MUTAGEN_33_33.RAs5Z3cdZJ2NWx7LfzW-YJhPErDFDZvwxmOo7EX_3vE_A._3 comment "Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." NX_Q9NZC7-2_MUTAGEN_33_33.RAs5Z3cdZJ2NWx7LfzW-YJhPErDFDZvwxmOo7EX_3vE_A.assertion.
- NX_Q9NZC7-4_MUTAGEN_33_33.RAqGM5-OTQfF8NR9S78E6kMeTx0ZgoEuGKfoYC3HEyy-k._4 comment "Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." NX_Q9NZC7-4_MUTAGEN_33_33.RAqGM5-OTQfF8NR9S78E6kMeTx0ZgoEuGKfoYC3HEyy-k.assertion.
- NX_Q9NZC7-5_MUTAGEN_33_33.RAh-OGkIwXvUk3er3ERid6Ce9QBxZ5kLo3FXUl5MXHZ5c._4 comment "Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." NX_Q9NZC7-5_MUTAGEN_33_33.RAh-OGkIwXvUk3er3ERid6Ce9QBxZ5kLo3FXUl5MXHZ5c.assertion.
- NX_Q9NZC7-6_MUTAGEN_33_33.RAOsTAyxAw9sVyu-EjaCIxBi6uUnMBVTKTXR6scfDBF-0._4 comment "Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." NX_Q9NZC7-6_MUTAGEN_33_33.RAOsTAyxAw9sVyu-EjaCIxBi6uUnMBVTKTXR6scfDBF-0.assertion.
- NX_Q9NZC7-7_MUTAGEN_33_33.RAF7cve4yf_B8oLPZBbhoAego__3tjCE1tsPgyCbAlm6s._4 comment "Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." NX_Q9NZC7-7_MUTAGEN_33_33.RAF7cve4yf_B8oLPZBbhoAego__3tjCE1tsPgyCbAlm6s.assertion.
- NX_Q9NZC7-3_MUTAGEN_33_33.RA9eLCHjGr9D2s-3s-h8fa9TaHaZd9ZQc3fC_ubXV04GQ._4 comment "Abolishes interaction with TP53, TP73, MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity." NX_Q9NZC7-3_MUTAGEN_33_33.RA9eLCHjGr9D2s-3s-h8fa9TaHaZd9ZQc3fC_ubXV04GQ.assertion.